Dean Coston


Recruitment Specialist


Dean Started with Regulatory Compliance Associates® Inc.‘s in March 2021 as a CDP employee where he was able to spend time in each department in the company to learn their functions and has settled into a recruiting role as a Recruitment Specialist.

As a Recruitment Specialist, Dean Coston is responsible for recruiting, screening, and onboarding consultants for opportunities. He works with the Business Development Team to find the right consultants for each opportunity and continually works to enrich our growing pool of consultants.

Prior to joining RCA, Dean spent a year at Insideout as a Sales Innovation Representative nurturing accounts, prospecting new clients, and developing scopes of work for new projects.

Dean has a Bachelor of Arts in Communication and a Minor in Marketing from Flagler College in St. Augustine, Florida. He is based out of our Southeastern office in Oldsmar, Florida in the greater Tampa Bay area.

 

About RCA

 

pharmaceutical consultantsRegulatory Compliance Associates® (RCA) provides worldwide services to the following industries for resolution of compliance and regulatory challenges:

 

We understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA-and globally-regulated companies.

As your partners, we can negotiate the potential minefield of regulatory compliance and private equity due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.

 

To begin the RCA® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage. 

News

Parenteral Products Sterilization and Extractables Evaluation to Help Ensure Drug Safety...
Read More

News

Parenteral Products Sterilization and Extractables Evaluation to Help Ensure Drug Safety...
Read More

News

Our website uses cookies to give you the best possible experience.

By continuing to use this site, you agree to the use of cookies.
Continue